|Bid||1.50 x 1800|
|Ask||13.90 x 800|
|Day's Range||13.75 - 14.43|
|52 Week Range||13.75 - 29.09|
|Beta (5Y Monthly)||2.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
As many shareholders of Mersana Therapeutics, Inc. ( NASDAQ:MRSN ) will be aware, they have not made a gain on their...
ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021
Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -28.21% and -95.60%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?